Showing results (1-10 of 202) with videos related to

Sort By:
Pageof 21
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 19, 2004
Continuous release of rh-interferon alpha-2a from triglyceride matricesSilke Mohl, Gerhard Winter
Pharmaceutical Development and Technology|March 21, 2006
Continuous release of Rh-interferon (alpha-2a from triglyceride implants: storage stability of the dosage formsSilke Mohl, Gerhard Winter
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 29, 2006
NIR spectroscopy-a non-destructive analytical tool for protein quantification within lipid implantsTilo Schönbrodt, Silke Mohl, Gerhard Winter, et al.
Pharmaceutical Research|March 24, 2007
New insight into the role of polyethylene glycol acting as protein release modifier in lipidic implantsSandra Herrmann, Silke Mohl, Florence Siepmann, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 6, 2007
Mechanisms controlling protein release from lipidic implants: effects of PEG additionSandra Herrmann, Gerhard Winter, Silke Mohl, et al.
The Journal of Pharmacy and Pharmacology|May 5, 2017
Challenges for the pharmaceutical technical development of protein coformulationsClaudia Mueller, Ulrike Altenburger, Silke Mohl
PDA Journal of Pharmaceutical Science and Technology|June 2, 2018
Evaluation of Container Closure System Integrity for Storage of Frozen Drug Products: Impact of Capping Force and TransportationAlejandra Nieto, Holger Roehl, Michael Adler, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 6, 2009
Lipid extrudates as novel sustained release systems for pharmaceutical proteinsSandra Schulze, Gerhard Winter
Pharmaceutical Development and Technology|May 9, 2007
Application and drying of protein drug microdroplets on solid surfacesAnke Stabenau, Gerhard Winter
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 7, 2004
The use of asymmetrical flow field-flow fractionation in pharmaceutics and biopharmaceuticsWolfgang Fraunhofer, Gerhard Winter
Pageof 21